ENLV: Enlivex Therapeutics Ltd. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 22.21
Enterprise Value ($M) 19.44
Book Value ($M) 26.59
Book Value / Share 1.21
Price / Book 0.84
NCAV ($M) 23.90
NCAV / Share 1.09
Price / NCAV 0.93

Profitability (mra)
Return on Invested Capital (ROIC) -0.69
Return on Assets (ROA) -0.51
Return on Equity (ROE) -0.63

Liquidity (mrq)
Quick Ratio 9.71
Current Ratio 9.71

Balance Sheet (mrq) ($M)
Current Assets 27.11
Assets 29.80
Liabilities 3.21
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income 0.00
Net Income 0.00

Cash Flow Statement (mra) ($M)
Cash From Operations 0.00
Cash from Investing 0.00
Cash from Financing 0.00

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
02-14 13G/A Armistice Capital, Llc

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-02-21 10,421 42,433 24.56
2025-02-20 12,630 33,746 37.43
2025-02-19 18,996 67,532 28.13
2025-02-18 15,662 46,124 33.96

(click for more detail)

Similar Companies
ELDN – Eledon Pharmaceuticals, Inc. ELTX – Elicio Therapeutics, Inc.
ELUT – Elutia Inc. ENSC – Ensysce Biosciences, Inc.
ENTO – Entero Therapeutics, Inc.


Financial data and stock pages provided by
Fintel.io



This entry was posted in . Bookmark the permalink.